Infection chains and evolution rates of hepatitis B virus in cardiac transplant recipients infected nosocomially

Journal of Medical Virology

Volumn 58, Issue 1, 1999, Pages 1-10

  Petzold, Dieter R ^a   Tautz, Bernhard ^a   Wolf, Friedhelm ^a   Drescher, Joachim ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

'a' epitope; Antigens; DNA sequencing; Enhancer; HBV

Indexed keywords

CORE PROTEIN; DNA BASE; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DNA SEQUENCE; EPIDEMIC; EVOLUTION; HEART TRANSPLANTATION; HEPATITIS B; HEPATITIS B VIRUS; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NUCLEOTIDE SEQUENCE; PERSISTENT VIRUS INFECTION; RECIPIENT; SEROTYPE; VIRUS ISOLATION;

CROSS INFECTION; DISEASE OUTBREAKS; DNA, VIRAL; EVOLUTION, MOLECULAR; HEART TRANSPLANTATION; HEPATITIS B; HEPATITIS B VIRUS; HUMANS;

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 0032954188     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199905)58:1<1::AID-JMV1>3.0.CO;2-M     Document Type: Article

References (63)

1. Barnes WM, 1992. The fidelity of Taq polymerase catalyzing PCR is improved by an N-terminal deletion. Gene 112:29-35.
2. Bartholomew MM, Jansen RW, Jeffers LJ, Reddy KR, Johnson LC, Bunzendahl H, Condreay LD, Tzakis AG, Schiff ER, Brown NA. 1997. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 349: 20-22.
3. Blum HE. 1993. Hepatitis B virus: significance of naturally occurring mutants. Intervirology 35:40-50.
4. Blum HE. 1995. Variants of hepatitis B, C and D viruses: molecular biology and clinical significance. Digestion 56:85-95.
5. Bowyer SH, van Staden L, Kew MC, Sim JGM. 1997. A unique segment of hepatitis B virus group A genotype identified in isolates from South Africa. J Gen Virol 78:1719-1729.
6. Bozkaya H, Akarca US, Ayola B, Lok ASF. 1997. High degree of conservation in the hepatitis B virus core gene during the immune tolerant phase in perinatally acquired chronic hepatitis B virus infection. J Hepatol 26:508-516.
7. Brind A, Jiang J, Samuel D, Gigou M, Feray C, Bréchot C, Kremsdorf D. 1997. Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection. J Hepatol 26:228-235.
8. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckermann AJ, Thomas HC. 1990. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325-329.
9. Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R. 1995. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 345:1406-1407.
10. Cong YS, Yao YL, Yang WM, Kuzhandaivelu N, Seto E. 1997. The hepatitis B virus X-associated protein, XAP3, is a protein kinase C-binding protein. J Biol Chem 272:16482-16489.
11. Corpet F. 1989. Multiple sequence alignment with hierarchical clustering. Nucl Acids Res 16:10881-10890.
12. Couroucé-Pauty AM, Plancon A, Soulier JP. 1983. Distribution of HBsAg subtypes in the world. Vox Sanguinis 44:197-211.
13. David E, Garcia AD, Hearing P. 1995. Interaction of EF-C/RFX-1 with the inverted repeat of viral enhancer regions is required for trans-activation. J Biol Chem 270:8353-8360.
14. Drescher J, Wagner D, Haverich A, Flik J, Stachan-Kunstyr R, Verhagen W, Wagenbreth I. 1994. Nosocomial hepatitis B virus infec tions in cardiac transplant recipients transmitted during transvenous endomyocardial biopsy. J Hosp Infect 26:81-92.
15. Fortuin M, Karthigesu V, Allison L, Howard C, Hoare S, Mendy M, Whittle HC. 1994. Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine. J Infect Dis 169:1374-1376.
16. Galibert F, Mandart E, Fitoussi F, Tiollais P, Charnay P. 1979. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281:646-650.
17. Girones R, Miller RH. 1989. Mutation rate of the hepadnavirus genome. Virology 170:595-597.
18. Günther S, Li B-C, Miska S, Krüger DH, Meisel H, Will H. 1995. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 69:5437-5444.
19. Harpaz R, von Seidlen L, Averhoff FM, Tormey MP, Sinha SD, Kotsopoulou K, Lambert SB, Robertson BH, Cherry JD, Shapiro CN. 1996. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med 334:549-554.
20. Hildt E, Saher G, Bruss V, Hofschneider PH. 1996. The hepatitis B virus surface protein (LHBs) is a transcriptional activator. Virology 225:235-239.
21. Hou J, Karayiannis P, Waters J, Luo K, Liang C, Thomas HC. 1995. A unique insertion in the S gene of surface antigen-negative hepatitis B virus Chinese carriers. Hepatology 21:273-278.
22. Howard CR, Allison LMC. 1995. Hepatitis B surface antigen variation and protective immunity. Intervirology 38:35-40.
23. Kaneko M, Uchida T, Moriyama M, Arakawa Y, Shikata T, Gotroh K, Mima S. 1995. Probable implication of mutations of the X open reading frame in the onset of fulminant hepatitis B. J Med Virol 47:204-208.
24. Karthigesu VD, Allison LMC, Fortuin M, Mendy M, Whittle HC, Howard CR. 1994. A novel hepatitis B virus variant in the sera of immunized children. J Gen Virol 75:443-448.
25. Kidd-Ljunggren K, Öberg M, Kidd AH. 1995. The hepatitis B virus X gene: analysis of functional domain variation and the gene phylogeny using multiple sequences. J Gen Virol 76:2119-2130.
26. Kremsdorf D, Carreau F, Duclos H, Thiers V, Schellekens H, Petit MA, Bréchot C. 1993. Complete nucleotide sequence and viral envelope protein expression of a hepatitis B virus DNA derived from a hepatitis B surface antigen-seronegative patient. J Hepatol 18: 244-250.
27. Kwee L, Lucito R, Aufiero B, Schneider RJ. 1992. Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters. J Virol 66:4382-4389.
28. Lee H, Lee Y-H, Huh Y-S, Moon H, Yun Y. 1995. X-gene product antagonizes the p53-mediated inhibition of hepatitis B virus replication through regulation of the pregenomic/core promoter. J Biol Chem 270:31405-31412.
29. Lee PI, Chang LY, Lee CY, Huang LM, Chang MH. 1997. Detection of hepatitis B surface gene mutation in carrier children with or without immunoprophylaxis at birth. J Infect Dis 176:427-430.
30. Lin HJ, Lai C, Lauder IJ, Wu P, Lau TK, Fong M. 1991. Application of hepatitis B virus (HBV) DNA sequence polymorphisms to the study of HBV transmission. J Infect Dis 164:284-288.
31. Magnius LO, Norder H. 1995. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology 38:24-34.
32. McMahon G, Ehrlich PH, Moustafa ZA, McCarthy LA, Dottavio D, Tolpin MD, Nadler PI, Östberg L. 1992. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 15:757-766.
33. Mimms L. 1995. Hepatitis B virus escape mutants: "pushing the envelope" of chronic hepatitis B virus infection. Hepatology 21:884-887.
34. Moriyama K, Nakajima E, Hohjoh H, Asayama R, Okochi K. 1991. Immunoselected hepatitis B virus mutant. Lancet 337:125.
35. Murakami S, Cheong JH, Kaneko S. 1994. Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein. J Biol Chem 269:15118-15123.
36. Norder H, Couroucé AM, Magnius LO. 1992. Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J Gen Virol 73:3141-3145.
37. Norder H, Hammas B, Lee SD, Bile K, Couroucé AM, Mushahawar IK, Magnius LO. 1993. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol 74:1341-1348.
38. Okamoto H, Imai M, Shimozaki M, Hoshi Y, Iizuka H, Gotanda T, Tsuda F, Miyakawa Y, Mayumi M. 1986. Nucleotide sequence of a cloned hepatitis B virus genome, subtype ayr: comparison with genomes of the other three subtypes. J Gen Virol 67:2305-2314.
39. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, Mayumi M. 1988. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 69:2575-2583.
40. Okamoto H, Yano K, Nozaki Y, Matsui A, Miyazaki H, Yamamoto K, Tsuda F, Machida A, Mishiro S. 1992. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res 32:264-268.
41. Ono Y, Onda H, Sasada R, Igarashi K, Sugino Y, Nishioka K. 1983. The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucl Acids Res 11:1747-1757.
42. Ori A, Shaul Y. 1995. Hepatitis B virus enhancer binds and is activated by the hepatocyte nuclear factor 3. Virology 207:98-106.
43. Orito E, Mizokami M, Ina Y, Moriyama EN, Kameshima N, Yamamoto M, Gojobori T. 1989. Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences. Proc Natl Acad Sci USA 87:7059-7062.
44. Osterhaus A, Voss MC, Balk A, de Man RA, Mouton JW, Rothbarth PH, Schalm SW, Tomaello AM, Niesters HGM, Verbrugh HA. 1998. Transmission of hepatitis B virus among heart transplant recipients during endomyocardial biopsy procedures. J Heart Lung Transplant 17:158-166.
45. Pollicino T, Pernice F, Campo S, Mesiti O, Misefari V, Pernice M, Raimondo G. 1996. Severe outcome of hepatitis B virus (HBV) infection and lack of HBV e antigen-defective virus emergence in patients homozygous for HLA class I alleles. J Gen Virol 77:1833-1836.
46. Qadri I, Maguire H, Siddiqui A. 1995. Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. Proc Natl Acad Sci USA 92:1003-1007.
47. Radziwill G, Tucker W, Schaller H. 1990. Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol 64:613-620.
48. Raney AK, Le HB, McLachlan A. 1992. Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor. J Virol 66:6912-6921.
49. Rehermann B, Pasquinelli C, Mosier SM, Chisari FV. 1995. Hepatitis B virus (HBV) sequence variation in cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. J Clin Invest 96:1527-1534.
50. Roll M, Norder H, Magnius LO, Grillner L, Lindgren V. 1995. Nosocomial spread of hepatitis B virus (HBV) in a haemodialysis unit confirmed by HBV DNA sequencing. J Hosp Infect 30:57-63.
51. Santantonio T, Jung MC, Pastore G, Angarano G, Günther S, Will H. 1997. Familial clustering of HBV pre-C and pre-S mutants. J Hepatol 26:221-227.
52. Sterneck M, Günther S, Santantonio T, Fischer L, Broelsch CE, Greten H, Will H. 1996. Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation. Hepatology 24:300-306.
53. Sterneck M, Günther S, Gerlach J, Naoumov NV, Santantonio T, Fischer L, Rogiere X, Greten H, Williams R, Will H. 1997. Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis. J Hepatol 26:754-764.
54. The Incident Investigation Teams and Others. 1997. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen. N Engl J Med 336:178-184.
55. Tindall KR, Kunkel TA. 1988. Fidelity of DNA synthesis by Thermus aquaticus DNA polymerase. Biochemistry 27:6008-6013.
56. Uy A, Wunderlich G, Olsen DB, Heermann KH, Gerlich WH, Thornssen R. 1992. Genomic variability in the preS1 region and determination of routes of transmission of hepatitis B virus. J Gen Virol 73:3005-3009.
57. Wallace LA, Echevarria JE, Echevarria JM, Carman WF. 1994. Molecular characterization of envelope antigenic variants of hepatitis B virus from Spain. J Infect Dis 170:1300-1303.
58. Waters JA, Kennedy M, Voet P, Hauser P, Petre J, Carman W, Thomas HC. 1992. Loss of the common "a" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J Clin Invest 90:2543-2547.
59. von Weizsäcker F, Pult I, Geiss K, Wirth S, Blum HE. 1995. Selective transmission of variant genomes from mother to infant in neonatal fulminant hepatitis B. Hepatology 21:8-13.
60. Wu X, Zhu L, Li Z-P, Koshy R., Wang Y. 1992. Functional organization of enhancer (ENII) of hepatitis B virus. Virology 191:490-494.
61. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, Okamoto H, Miyakawa Y, Mayumi M. 1994. Naturally occurring escape mutants of hepatitis B virus with various mutations in the gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 68:2671-2676.
62. Yuh CH, Chang YL, Ting LP. 1992. Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. J Virol 66:4073-4084.
63. Zuckerman MA, Hawkins AE, Briggs M, Waite J, Balfe P, Thom B, Gilson RJC, Tedder RS. 1995. Investigation of the hepatitis B virus transmission in a health care setting: application of direct sequence analysis. J Infect Dis 172:1080-1083.